Marshall Wace, LLP Edwards Lifesciences Corp Transaction History
Marshall Wace, LLP
- $72.2 Billion
- Q2 2024
A detailed history of Marshall Wace, LLP transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Marshall Wace, LLP holds 74,666 shares of EW stock, worth $4.97 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
74,666
Previous 178,994
58.29%
Holding current value
$4.97 Million
Previous $17.1 Million
59.68%
% of portfolio
0.01%
Previous 0.03%
Shares
27 transactions
Others Institutions Holding EW
# of Institutions
1,417Shares Held
470MCall Options Held
2.44MPut Options Held
2.65M-
Vanguard Group Inc Valley Forge, PA53.6MShares$3.57 Billion0.1% of portfolio
-
Black Rock Inc. New York, NY51MShares$3.39 Billion0.11% of portfolio
-
State Street Corp Boston, MA26MShares$1.73 Billion0.11% of portfolio
-
Alliancebernstein L.P. New York, NY20.3MShares$1.35 Billion0.68% of portfolio
-
Wellington Management Group LLP Boston, MA16.9MShares$1.13 Billion0.29% of portfolio
About Edwards Lifesciences Corp
- Ticker EW
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 618,259,968
- Market Cap $41.2B
- Description
- Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...